HCP: Appropriate Use of SGLT2 Inhibitors in Type 2 Diabetes

HCP: Appropriate Use of SGLT2 Inhibitors in Type 2 Diabetes

View Resource

Published: 25-01-2019

Review Date: 01/01/0001 00:00:00